financetom
Business
financetom
/
Business
/
Unifirst's Q3 Earnings: Revenue And Profit Beat, Strong Outlook And More
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Unifirst's Q3 Earnings: Revenue And Profit Beat, Strong Outlook And More
Jun 26, 2024 9:27 AM

Unifirst Corporation ( UNF ) shares are trading higher after the company reported better-than-expected third quarter financial results.

Quarterly sales of $603.33 million beat the analyst consensus of $601.29 million.

Unifirst ( UNF ) registered first quarter operating income of $48.5 million, an increase of 45.1% year over year.

The company clocked diluted earnings per share of $2.03, up 57.4% year over year. On an adjusted basis, Unifirst ( UNF ) clocked earnings per share of $2.19, beating the street view of $1.86.

Adjusted EPS excludes approximately $3.9 million in costs directly attributable to its customer relationship management computer system and enterprise resource planning project.

Third-quarter EBITDA increased to $82.5 million compared to $64.0 million in the prior year.

Unifirst ( UNF ) said its cash, cash equivalents, and short-term investments totaled $125.4 million as of May 25, with no long-term debt outstanding.

Outlook: Unifirst ( UNF ) reiterated its FY24 outlook. The company sees revenues of $2.415 billion to $2.425 billion versus the $2.42 billion estimate. It projects EPS of $7.17 to $7.49 versus the $7.45 estimate.

The company estimates around $12.0 million of costs directly attributable to its key initiatives that will be expensed in fiscal 2024.

“Our outlook for fiscal 2024 includes one extra week of operations compared to fiscal 2023 due to the timing of our fiscal quarter,” said CEO Steven Sintros.

Price Action: UNF shares are trading higher by 13.30% to $175.09 at the last check on Wednesday.

Read Next: Why Southwest Airlines Shares Are Falling Today

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Adtran, Netomnia Collaborate to Offer 50 Gigabits per Second Network Services in UK
Adtran, Netomnia Collaborate to Offer 50 Gigabits per Second Network Services in UK
Oct 9, 2024
11:04 AM EDT, 10/08/2024 (MT Newswires) -- Adtran ( ADTN ) and Netomnia are collaborating to bring 50 gigabits per second passive optical network services to the UK. The network upgrade won't disrupt existing optical distribution systems, and the 50 gigabits per second passive optical network technology will integrate seamlessly with existing setups, the company said Tuesday in a statement....
UBS 'bang on target' with Credit Suisse integration, IT chief says
UBS 'bang on target' with Credit Suisse integration, IT chief says
Oct 9, 2024
ZURICH (Reuters) - UBS's integration of former rival Credit Suisse's clients and data with its own platforms is bang on target after a successful test run, its tech chief told Reuters. UBS CEO Sergio Ermotti has previously flagged that IT integration is one of the biggest risks facing UBS as it embarks on the second, trickier phase of merging with...
Airship AI Gets $1.2 Million Contract for Video, Data Management Platform Support
Airship AI Gets $1.2 Million Contract for Video, Data Management Platform Support
Oct 9, 2024
11:04 AM EDT, 10/08/2024 (MT Newswires) -- Airship AI Holdings ( AISP ) said Tuesday it secured a $1.2 million contract with a Fortune 100 transportation and e-commerce firm to support and maintain an existing globally deployed Acropolis Enterprise Video and Data Management platform over the next nine months. The platform is designed to enhance the company's operational and physical...
GSK shares seen opening higher after settlement of 80,000 Zantac lawsuits
GSK shares seen opening higher after settlement of 80,000 Zantac lawsuits
Oct 9, 2024
(Reuters) - Shares of GSK are seen rising 5% according to pre-market indications on Thursday after the British drugmaker agreed to pay up to $2.2 billion to settle lawsuits that claimed its discontinued heartburn drug Zantac caused cancer. The agreement, announced on Wednesday, resolved 80,000 or 93% of the pending cases against the company in the U.S. and was far...
Copyright 2023-2026 - www.financetom.com All Rights Reserved